Trial of EDG-5506, Becker MD Treatment, Begins Enrolling Patients | Oral Therapy Aims to Preserve Muscle Health
A Phase 2 scientific demo testing Edgewise Therapeutics’ investigational oral therapy EDG-5506 is recruiting boys and adult males with Becker muscular dystrophy (BMD). Identified as CANYON (NCT05291091), the review plans…







